India, March 17 -- During Tuesday's trading session, shares of a company manufacturing sponge iron, power generation and mining activities, surged more than 8 percent on BSE. So, what triggered this s... Read More
భారతదేశం, మార్చి 17 -- దక్షిణ అమెరికా దేశమైన వెనిజులాను అమెరికాలో 51వ రాష్ట్రంగా చేరాలని ట్రంప్ ఒక సోషల్ మీడియా పోస్ట్ చేశారు. సుమారు ఏడేళ్ల విరామం తర్వాత వాషింగ్టన్, కరాకస్ మధ్య దౌత్య సంబంధాలు పునరుద... Read More
Nigeria, March 17 -- At least 15 people have been killed after suspected bandits launched a reprisal attack on communities in Jibia Local Government Area of Katsina State on Tuesday, in what appears t... Read More
Jakarta, March 17 -- Home Affairs Minister Tito Karnavian has called on regional governments in Sumatra to speed up data collection for residents set to receive permanent housing following floods and ... Read More
U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07473128) titled 'Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage ... Read More
U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07472764) titled 'Auricular Acupressure for Reducing Postoperative Emergence Agitation in Preschool Children... Read More
U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07474363) titled 'Gender Differences in Depression Severity, Gender-Sensitive Symptoms, Resilience, and Stig... Read More
U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07472582) titled 'A Chatbot to Reduce Chemsex and HIV-related Risk Behaviors Among Men Who Have Sex With Men... Read More
U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07473531) titled 'Chatbot to Support Healthcare Professionals Experiencing Workplace Aggression' on March 09... Read More
U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07472322) titled 'ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1' on... Read More